{"article_title": "One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug", "article_keywords": ["bestselling", "futures", "drug", "goes", "biggest", "pharmas", "enemies"], "article_url": "http://www.forbes.com/sites/matthewherper/2014/03/24/one-of-pharmas-biggest-enemies-goes-after-the-futures-best-selling-drug/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Matthew Herper", "og": {"site_name": "Forbes", "description": "Over the past two decades, U.S. Representative Henry Waxman has given the drug industry good reason to fear him. Waxman (D.-California) humiliated Merck in open hearings by publicizing sales training materials that indicated the company had instructed its reps to deliberately downplay the heart risks of the pain pill Vioxx -- [...]", "title": "One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug", "url": "http://www.forbes.com/sites/matthewherper/2014/03/24/one-of-pharmas-biggest-enemies-goes-after-the-futures-best-selling-drug/", "image": "http://blogs-images.forbes.com/matthewherper/files/2014/03/185725395.jpg", "updated_time": "2014-03-24T10:48:48-04:00", "type": "article"}, "twitter": {"description": "Over the past two decades, U.S. Representative Henry Waxman has given the drug industry good reason to fear him. Waxman (D.-California) humiliated Merck in open hearings by publicizing sales training materials that indicated the company had instructed its reps to deliberately downplay the heart risks of the pain pill Vioxx -- [...]", "title": "One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug", "image": "http://blogs-images.forbes.com/matthewherper/files/2014/03/185725395.jpg", "creator": "@matthewherper", "site": "@forbes", "card": "summary_large_image"}, "description": "Over the past two decades, U.S. Representative Henry Waxman has given the drug industry good reason to fear him. Waxman (D.-California) humiliated Merck in open hearings by publicizing sales training materials that indicated the company had instructed its reps to deliberately downplay the heart risks of the pain pill Vioxx -- [...]", "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Pharma and Health,Pharma &amp; Healthcare,Bristol-Myers Squibb,Diana DeGette,Food and Drug Administration,Gilead Sciences,New Jersey", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/herper", "section_url": "http://www.forbes.com/healthcare", "section": "Pharma & Healthcare", "modified": "2014-03-24", "published": "2014-03-24", "id": "blogAndPostId/blog/post/973-10205"}, "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "news_keywords": "Pharma and Health,Pharma &amp; Healthcare,Bristol-Myers Squibb,Diana DeGette,Food and Drug Administration,Gilead Sciences,New Jersey"}, "_id": "\"57477af36914bd0286fcc722\"", "article_summary": ""}